REAL-WORLD PRACTICE PATTERNS, CLINICAL AND ECONOMIC OUTCOMES AMONG US PATIENTS WITH TYPE 2 DIABETES INITIATING ONCE-DAILY INJECTABLE PEN THERAPY WITH INSULIN GLARGINE OR LIRAGLUTIDE

被引：0
|
作者：
Raparla, Swetha [1 ]
Wei, Wenhui [2 ]
Grabner, Michael [1 ]
Cuddihy, Robert M. [2 ]
Hu, Wenli [2 ]
Quimbo, Ralph [1 ]
机构：
[1] HealthCore Inc, Wilmington, DE USA
[2] Sanofi Aventis US, Bridgewater, NJ USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S293 / S293
页数：1
相关论文
共 50 条
  • [1] Real-World Outcomes of Initiating Injectable Therapy With Insulin Glargine or Liraglutide Among Patients With Type 2 Diabetes
    Levin, Philip
    Wei, Wenhui
    Vlajnic, Aleksandra
    Pan, Chunshen
    Xie, Lin
    Lin, Jay
    Baser, Onur
    [J]. DIABETES, 2012, 61 : A4 - A4
  • [2] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES WHEN INITIATING ONCE-DAILY INJECTABLE PEN THERAPY WITH INSULIN GLARGINE OR LIRAGLUTIDE - AN ELECTRONIC MEDICAL RECORDS STUDY
    Mersey, J.
    Wei, W.
    Meyers, J.
    Wang, C. C.
    Dalal, M. R.
    Bromberger, L. A.
    Levin, P.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A494 - A494
  • [3] The INITIATOR study: real-world treatment patterns and outcomes in patients with type 2 diabetes initiating insulin glargine or liraglutide
    Levin, P. A.
    Wei, W.
    Buysman, E.
    Thayer, S.
    Brekke, L.
    Crown, W. H.
    Grabner, M.
    Ke, X.
    Quimbo, R. A.
    Cziraky, M. J.
    Hu, W.
    Cuddihy, R.
    Chu, J. W.
    [J]. DIABETOLOGIA, 2014, 57 : S53 - S54
  • [4] Real-World Practice Pattern and Outcomes of Patients With Type 2 Diabetes (T2DM) Initiating Injectable Therapy via Insulin Glargine Disposable Pen (GLA-P) or Liraglutide (LIRA)
    Lin, Jay
    Wei, Wenhui
    Vlajnic, Aleksandra
    Pan, Chunshen
    Xie, Lin
    Baser, Onur
    Levin, Philip
    [J]. DIABETES, 2012, 61 : A286 - A286
  • [5] Real-world clinical and economic outcomes in patients with type 2 diabetes initiating glargine disposable pen vs. insulin detemir disposable pen in a US managed care setting
    Xie, L.
    Wei, W.
    Pan, C.
    Du, J.
    Baser, O.
    [J]. DIABETOLOGIA, 2011, 54 : S415 - S415
  • [6] Real-world characteristics of patients with type 2 diabetes initiating insulin glargine plus exenatide or insulin glargine plus liraglutide
    Di Genio, A.
    Ling, Z.
    Davis, K. L.
    Meyers, J. L.
    Dalal, M. R.
    [J]. DIABETOLOGIA, 2012, 55 : S328 - S328
  • [7] The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy
    Thayer, Sarah
    Wei, Wenhui
    Buysman, Erin
    Brekke, Lee
    Crown, William
    Grabner, Michael
    Raparla, Swetha
    Quimbo, Ralph
    Cziraky, Mark J.
    Hu, Wenli
    Cuddihy, Robert
    [J]. ADVANCES IN THERAPY, 2013, 30 (12) : 1128 - 1140
  • [8] The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy
    Sarah Thayer
    Wenhui Wei
    Erin Buysman
    Lee Brekke
    William Crown
    Michael Grabner
    Swetha Raparla
    Ralph Quimbo
    Mark J. Cziraky
    Wenli Hu
    Robert Cuddihy
    [J]. Advances in Therapy, 2013, 30 : 1128 - 1140
  • [9] Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
    Saunders, William B.
    Nguyen, Hiep
    Kalsekar, Iftekhar
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY, 2016, 9 : 217 - 223
  • [10] Clinical and Economic Outcomes Among Patients With Diabetes Mellitus Initiating Insulin Glargine Pen Versus Vial
    Grabner, Michael
    Chu, James
    Raparla, Swetha
    Quimbo, Ralph
    Zhou, Steve
    Conoshenti, Joseph
    [J]. POSTGRADUATE MEDICINE, 2013, 125 (03) : 204 - 213
12345